The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Arslanbekov M.M.
Division of Fundamental and Applied Researches in Surgery of the Research Institute of Clinical Surgery of the Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia
Efremova O.I.
Kafedra fakul'tetskoĭ khirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta, gorodskaia klinicheskaia bol'nitsa #1 im. N.I. Pirogova, Moskva
Lebedev I.S.
Pirogov Russian National Research Medical University, Moscow, Russia;
Municipal Clinical Hospital No. 1 named after N.I. Pirogov, Moscow, Russia
Zolotukhin I.A.
Pirogov Russian National Research Medical University, Moscow, Russia
Efficacy and Safety of Inferior Vena Cava Filters Implantation in Patients with Venous Thromboembolism
Journal: Journal of Venous Disorders. 2019;13(3): 236‑244
Views: 3242
Downloaded: 143
To cite this article:
Arslanbekov MM, Efremova OI, Lebedev IS, Zolotukhin IA. Efficacy and Safety of Inferior Vena Cava Filters Implantation in Patients with Venous Thromboembolism. Journal of Venous Disorders.
2019;13(3):236‑244. (In Russ.)
https://doi.org/10.17116/flebo201913031236
Literature data devoted to efficiency and safety of modern algorithms of inferior vena cava filter (CF) implantation for venous thromboembolic complications (VTEC) are reviewed in the article. One of the objectives of the review was analysis of whether an assessment of the balance of efficacy and safety of CF had been previously conducted. In the majority of trials, mortality and incidence of recurrent pulmonary embolism were compared to analyze efficacy of CF. CF implantation is followed by lifelong intake of anticoagulants with risks of bleeding or, conversely, thrombosis in case of inadequate anticoagulant therapy. Mortality cannot be the only criterion to assess efficacy of CF in prevention of VTEC. There are still no studies comparing patients with prevented pulmonary embolism (i.e. with embolic CF occlusion) and those without thrombus migration from the lower extremity veins. Current recommendations for CF insertion are not based on the same strict evidences as recommendations for anticoagulant therapy despite widespread clinical use of CF. American College of Chest Physicians guidelines are internationally accepted recommendations for CF deployment. In our country, guidelines of the Russian Association of Phlebologists are widely utilized. This document suggests expanded indications for cava filters insertion. Effectiveness and safety of certain recommendations of various expert groups are not still confirmed. Therefore, appropriate researches are required to assess positive and negative aspects of CF implantation in patients with VTEC.
Authors:
Arslanbekov M.M.
Division of Fundamental and Applied Researches in Surgery of the Research Institute of Clinical Surgery of the Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia
Efremova O.I.
Kafedra fakul'tetskoĭ khirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta, gorodskaia klinicheskaia bol'nitsa #1 im. N.I. Pirogova, Moskva
Lebedev I.S.
Pirogov Russian National Research Medical University, Moscow, Russia;
Municipal Clinical Hospital No. 1 named after N.I. Pirogov, Moscow, Russia
Zolotukhin I.A.
Pirogov Russian National Research Medical University, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.